SNPS.NASDAQSynopsys INC

Form 4: Synopsys CEO Ghazi Granted 19,856 Restricted Stock Units

Sentiment:

Insider Transaction


Synopsys, Inc. President and CEO Sassine Ghazi was granted 19,856 restricted stock units under the company's 2006 Employee Equity Incentive Plan.

Summary

  • Sassine Ghazi, President and CEO of Synopsys Inc. (SNPS), was granted 19,856 Restricted Stock Units (RSUs).
  • The transaction date for this grant was December 16, 2025.
  • The RSUs were granted under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.
  • The grant price for these RSUs was $0.0.
  • One-sixth (1/6) of the units will vest on June 15, 2026, followed by five equal semi-annual installments.
  • Vesting is contingent upon continued service through each vesting date.
  • The expiration date for these Restricted Stock Units is December 15, 2028.
  • Following this transaction, Sassine Ghazi beneficially owns 19,856 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to the CEO is a positive for aligning executive incentives with shareholder value, but it is a routine compensation event rather than a significant operational or financial announcement that would drastically alter the company's outlook.

Positives

  • The grant of restricted stock units to the President and CEO aligns management's long-term interests with those of shareholders, incentivizing sustained performance.
  • Equity-based compensation is a standard practice that helps attract and retain top executive talent in competitive industries.

Future Outlook

The filing details a vesting schedule for the granted restricted stock units, with the first tranche vesting on June 15, 2026, and subsequent semi-annual installments, subject to continued service. This indicates a long-term incentive structure for the CEO.

Management Comments

  • The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

Industry Context

The grant of restricted stock units to a top executive is a common practice in the technology industry and publicly traded companies. It serves as a key component of executive compensation packages, designed to align the interests of management with those of shareholders by tying a portion of compensation to the company's stock performance over time.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a form of executive compensation is a standard practice across the technology sector and global public companies, comparable to compensation structures at peers like Cadence Design Systems or NVIDIA.
  • The vesting schedule, typically over several years and contingent on continued service, is consistent with industry benchmarks for long-term incentive plans, aiming to retain executives and encourage sustained performance.
  • The grant of RSUs at a $0.0 price is standard for such awards, as they represent a right to receive shares upon vesting, rather than an option to purchase.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation ApprovalThe Compensation Committee of the Board of Directors approved the restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan, demonstrating standard corporate governance in executive compensation.December 16, 2025This approval reflects the board's oversight of executive compensation, ensuring that incentive plans are formally sanctioned and align with company policies.

Related Party Transactions

  • The grant of 19,856 restricted stock units to Sassine Ghazi, the President and CEO, constitutes a related party transaction as it involves compensation to a key executive. This is a standard and disclosed form of executive compensation.

Stakeholder Impact

  • Shareholders: The RSU grant aims to align the CEO's long-term interests with shareholder value creation, potentially leading to improved company performance.
  • Employees: This event is part of the company's overall compensation strategy, which may influence employee morale and retention by demonstrating commitment to executive incentives.

Next Steps

  • The restricted stock units will vest in installments, with the first vesting on June 15, 2026, and subsequent semi-annual installments, subject to Sassine Ghazi's continued service.

Key Dates

DateDescription
March 19, 2023Date of Power of Attorney for John Schwarz.
March 20, 2023Dates of Power of Attorney for Luis Borgen, Aart de Geus, Sassine Ghazi, Shelagh Glaser, Mercedes Johnson, and Jeannine Sargent.
March 21, 2023Dates of Power of Attorney for Janice Chaffin and Bruce Chizen.
March 28, 2023Execution date of Sassine E. Ghazi's Power of Attorney.
April 3, 2023Date of Power of Attorney for Sudhindra Kankanwadi.
July 28, 2023Date of Power of Attorney for Robert G. Painter.
December 11, 2025Execution date of Substitute Power of Attorney by Liz Ramirez and Anna Felix, appointing Mary Lai and Anthony Mawla respectively.
December 16, 2025Transaction date for the Restricted Stock Unit grant to Sassine Ghazi.
December 18, 2025Filing date of the Form 4 statement.
June 15, 2026First vesting date for one-sixth of the granted Restricted Stock Units.
December 15, 2028Expiration date of the Restricted Stock Units.

Recommendation

hold

This Form 4 filing details a routine restricted stock unit grant to the CEO, which is a standard executive compensation practice designed to align management's interests with shareholders. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral to the company's investment thesis.

Keywords

Synopsys, SNPS, Sassine Ghazi, Restricted Stock Units, RSU, Equity Grant, Executive Compensation, Insider Transaction, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.